跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOLIDIN CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/ 5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
ZOLIDIN CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/ 5 ML
Approved
THERAPEUTIC
ZOLIDIN CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/ 5 ML
INTAS PHARMACEUTICALS LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Jun 3, 2019
Approval ID
f6725d987dc31db4
Company
INTAS PHARMACEUTICALS LIMITED
Type
Therapeutic
Approval Details
Approval Id
f6725d987dc31db4
Drug Name
ZOLIDIN CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/ 5 ML
Product Name
ZOLIDIN CONCENTRATE FOR SOLUTION FOR INFUSION 4 MG/ 5 ML
Approval Number
SIN15707P
Approval Date
2019-06-03
Registrant
ACCORD HEALTHCARE PRIVATE LIMITED
Licence Holder
ACCORD HEALTHCARE PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
M05BA08
Atc Item Name
zoledronic acid
Pharma Manufacturer Name
ACCORD HEALTHCARE PRIVATE LIMITED
Company Detail Path
/organization/accord-healthcare-private-limited
Active Ingredients
Zoledronic Acid Monohydrate 4.264 mg eqv. zoledronic acid anhydrous
4 mg/vial
ZOLEDRONIC ACID MONOHYDRATE 4.264 MG EQV. ZOLEDRONIC ACID ANHYDROUS
4 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 3, 2019
Approval ID
f6725d987dc31db4
Type
Therapeutic
Back to HSA Approvals
